Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 4 Planned sale Chief Financial Officer sold 90,000 shares at $15.78 ($1,419,759)
  2. 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
  3. 4 Open-market buy Director bought 454,545 shares at $11.00 ($4,999,995)
  4. 4 Open-market buy Director bought 10,857 shares at $9.30 ($100,958)
  5. 4 Open-market sale General Counsel sold 8,497 shares at $10.50 ($89,219)
  6. 4 Open-market sale Chief Scientific Officer sold 172,585 shares at $9.33 ($1,610,097)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Exercise or conversion Chief Financial Officer acquired 10,000 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Business Officer sold 1,747 shares at $8.90 ($15,557)

Page 6 of 11 · 203 filings